Anand Reddi

Anand works on Gilead’s efforts to facilitate access to its medicines around the world.  His principal focus is catalyzing HIV and viral hepatitis health systems strengthening initiatives as well as innovative health financing partnerships in Africa and Asia.  He also currently leads Gilead’s partnership with The Vatican to develop a decentralized HIV Test & Treat initiative in Shinyanga, Tanzania.    

 Since joining Gilead in 2014, Anand has held several positions with experiences in Access Operations & Emerging Markets, Public Health & Medical Affairs, International Operations & Corporate Affairs and most recently the Chief Patient Officer organization focused on digital patient solutions.

 Prior to Gilead, Anand was active in basic science, public health and global health policy research.  His public health research focused on global HIV/AIDS.  He was previously a Fulbright Scholar in South Africa.  His research was one of the first to demonstrate the benefits of a decentralized model of care on pediatric antiretroviral treatment outcomes despite the challenges of a resource-limited setting. 

 Anand has also been active in global health policy issues.  His writings on global health have appeared in scientific journals such as Science, AIDS, and JAIDS as well as in the opinion pages of The Huffington Post (as a featured contributor), The Washington Post and The New York Times.